Top

International Journal of Diabetes in Developing Countries

Published in:

01-12-2011 | Editorial

Metabolic syndrome

Author: K. M. Prasanna Kumar

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2011

Excerpt

Metabolic syndrome (MS) is a constellation of individual risk factors of cardiovascular disease. The World Health Organization (WHO) was the first to publish an internationally accepted definition for metabolic syndrome in 1998, but the criteria that have received the most widespread acceptance and use in the United States are those established as guidelines in the ATP III (the third report of the National Cholesterol Education Program expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults). …

Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143–420.

Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237–52.PubMed

Jaggers JR, Sui X, Hooker SP, et al. Metabolic syndrome and risk of cancer mortality in men. Eur J Cancer. 2009;45:1831–8.PubMedCrossRef

Misra A, Khurana L. The metabolic syndrome in south Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009;7:497–514.PubMedCrossRef

Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. JAPI. 2009;57:163–70.PubMed

Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr. 2007;2:267–75.PubMedCrossRef

Reddy KS, Prabhakaran D, Chaturvedi V, Jeemon P, Thankappan KR, Ramakrishnan L, Mohan BV, Pandav CS, Ahmed FU, Joshi PP, Meera R, Amin RB, Ahuja RC, Das MS, Jaison TM. Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bull World Health Organ. 2006;84:461–9.PubMedCrossRef

Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004;97:257–61.PubMedCrossRef

Misra R, Misra A, Kamalamma N, Naval K, Vikram NK, Gupta S, Sharma S, Patel T, Balagopal P. Difference in prevalence of diabetes, obesity, metabolic syndrome and associated cardiovascular risk factors in a rural area of Tamil Nadu and an urban area of Delhi. Int J Diab Dev Ctries. 2011;31:82–90.CrossRef

10.

Mahadik SR, Deo SS, Mehtalia SD. Increased prevalence of metabolic syndrome in non-obese Asian Indian-an urban–rural comparison. Metab Syndr Relat Disord. 2007;5:142–52.PubMedCrossRef

11.

Kempegowda P, et al. Prevalence of Metabolic Syndrome in Rural India - A disparity in definitions. Int J Diab Dev Ctries. doi:10.1007/s13410-011-0046-y.

Title: Metabolic syndrome
Author: K. M. Prasanna Kumar
Publication date: 01-12-2011
Publisher: Springer-Verlag
Published in: International Journal of Diabetes in Developing Countries / Issue 4/2011
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-011-0056-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Metabolic syndrome

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2011

Are low dose pioglitazone combinations justifiable?

Glycemic and insulinemic responses to breakfast and succeeding second meal in type 2 diabetics

Prevalence of the metabolic syndrome in rural India—a disparity in definitions

Salivary total antioxidant capacity in type 2 diabetes mellitus patients—a clinical and biochemical study amongst tobacco smokers

Pseudoainhum of toes in type 2 diabetes

Angiotensin converting enzyme (ACE) gene polymorphism increases the susceptibility of diabetic nephropathy in Western Indian Type 2 diabetic patients

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page